Novo Nordisk shares rose over 5% in morning trade on Friday, ranking among the top gainers on the STOXX index, after investors reacted to trial results from Eli Lilly’s oral obesity drug candidate, orforglipron. The advance followed a 7% rally on Thursday, driven by data showing that Lilly’s pill resulted…
Global food commodity prices reached a two-year high in July, primarily due to increased international prices for meat and…
The Vanguard S&P 500 ETF (VOO) remained in a tight range this week as investor sentiment weakened and as…
Asian equities closed mostly lower on Friday as US President Donald Trump’s sweeping reciprocal tariffs against more than 90…
Match Group (NASDAQ: MTCH) shares jumped more than 14% on Wednesday after the online dating company delivered upbeat guidance…
Opendoor stock (NASDAQ: OPEN) took a major hit on Wednesday, as it plunged nearly 21% after a disappointing Q2…
Upstart Holdings Inc. (NASDAQ: UPST) tanked more than 18% on August 6th, even though the AI lending platform reported…
GLD ETF held steady on Wednesday, close to the two-week high reached in the previous session. The range-bound trading…
Asia-Pacific stock markets presented a mixed and somewhat volatile picture at Thursday’s open, as investors worked to decipher US…